Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics

Israel Medical Association Journal

Volumn 7, Issue 3, 2005, Pages 148-150

  Samra, Zmira ^a,b   Ofer, Orit ^a,b   Shmuely, Haim ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotic resistance; Methicillin resistance; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; METICILLIN; MINOCYCLINE; OFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; HOSPITAL PATIENT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ACETAMIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; PRISTINAMYCIN; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 15844430580     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Witte W. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999;44:1-9.
2. Samra Z, Gadba R, Ofir O. Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997. Eur J Clin Microbiol Infect Dis 2001;20:425-7.
3. LeMaitre N, Sougakoff W, Masmoudi A, Fievet MH, Bismuth R, Jarlier V. Characterization of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus involved in nosocomial spread. J Clin Microbiol 1998;36:81-5.
4. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson T, Tolson J. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-6.
5. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-15.
6. Bartlett M, McEntyre L, Moseley R, O'Conner J, Shaw J, Whitehead C. Methicillin-resistant S. aureus rates increase 260% in hospitals participating in HIP's international monitoring systems. Centers Dis Control Natl Center Infect Dis Focus 2000;9:4.
7. Van Griethuysen A, Van't Veen A, Buiting A, Walsh T, Kluytmans J. High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. J Clin Microbiol 2003;41:2487-91.
8. Denis O, Nonhoff B, Byl C, Knoop S, Bobin D, Struelens MJ. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. J Antimicrobiol Chemother 2002;50:383-91.
9. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-7.
10. Fridkin SK, Hageman J, McDougal LK, et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003;36:429-39.
11. Von Eiff C, Reinert RR, Kresken M, Bravers J, Hafner D, Peters G. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin. J Clin Microbiol 2000;38:2819-23.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7, NCCLS, 2003; Villanova, PA.
13. Skov R, Fridmodt-Möller N, Espersen F. Correlation of MIC methods and tentative interpretive criteria for disk diffusion susceptibility testing using NCCLS methodology for fusidic acid. Diagn Microbiol Infect Dis 2001;40:111-16.
14. Fagon JY, Patrick H, Haas DW, et al. Treatment of gram-positive nosocomial pneumonia: prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Am J Respir Crit Care Med 2000;161:753-62.
15. Sweeney MT, Zurenko GE. In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected gram-negative organisms. Antimicrob Agents Chemother 2003;47:1902-6.
16. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-82.
17. Stevens DL, Herr D, Lampiris H, Hunt JL, Batts HD, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34:1481-90.
18. Fukuda Y, Yanagihara K, Nakamura S, et al. Successful treatment with linezolid in two cases of methicillin resistant Staphylococcus aureus infections in orthopedic patients. Kansenshogaku Zasshi 2003;77:622-6.
19. Lyseng-Williamson KA, Goa KL. Linezolid: in infants and children with severe Gram-positive infections. Paediatr Drugs 2003;5:416-29.
20. Wagenlehner FM, Wydra S, Onda H, Kinzig-Schippers M, Sorgel F, Naber KG. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose. Antimicrob Agents Chemother 2003;47:3789-94.
21. Eykyn SJ. Staphylococcal bacteremia and endocarditis and fusidic acid. J Antimicrob Chemother 1990;25(Suppl B):33-8.
22. Bishara J, Pitlik S, Samra Z, Levy I, Paul M, Leibovici L. Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus Israel, 1988-1997. Emerging Infect Dis 2003;9:1168-9.
23. Denis O, Magdalena J, Deplano A, Nonhoff C, Hendrickx E, Struelens MJ. Molecular epidemiology of resistance to macrolides-lincosamides-streptogramins fin methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections in patients admitted to Belgian hospitals. J Antimicrob Chemother 2002;50:755-7.
24. Fung-Tomc J, Huczko E, Gradelski E, Denbleyker K, Bonner DP, Kessler RE. Emergence of homogeneously methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1991;29:2880-3.
25. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-8.